Skip to main content
Top
Published in: Diabetologia 11/2013

01-11-2013 | Letter

The diagnosis of insulitis in human type 1 diabetes

Authors: M. L. Campbell-Thompson, M. A. Atkinson, A. E. Butler, N. M. Chapman, G. Frisk, R. Gianani, B. N. Giepmans, M. G. von Herrath, H. Hyöty, T. W. Kay, O. Korsgren, N. G. Morgan, A. C. Powers, A. Pugliese, S. J. Richardson, P. A. Rowe, S. Tracy, P. A. In’t Veld

Published in: Diabetologia | Issue 11/2013

Login to get access

Excerpt

To the Editor: During a workshop concerning the histopathological characteristics of insulitis in human type 1 diabetes (fifth annual meeting of the JDRF Network for Pancreatic Organ Donors with Diabetes [nPOD], 10 February 2013, Jacksonville, FL, USA), a consensus opinion was reached on the criteria necessary for the diagnosis of insulitis, and a definition of insulitis was agreed, as detailed in the text box. Workshop attendees included many leading researchers in the field of beta cell biology and the pathology of human type 1 diabetes.
Consensus definition of insulitis
Patients with insulitis are defined by the presence of a predominantly lymphocytic infiltration specifically targeting the islets of Langerhans. The infiltrating cells may be found in the islet periphery (peri-insulitis), often showing a characteristic tight focal aggregation at one pole of the islet that is in direct contact with the peripheral islet cells. The infiltrate may also be diffuse and present throughout the islet parenchyma (intra-insulitis). The lesion mainly affects islets containing insulin-positive cells and is always accompanied by the presence of (pseudo)atrophic islets devoid of beta cells. The fraction of infiltrated islets is generally low (<10% of islet profiles). The lesion should be established in a minimum of three islets, with a threshold level of ≥15 CD45+ cells/islet before the diagnosis can be made. The pathology report should include the total number of islets analysed, the fraction of islets affected by insulitis, the fraction of (pseudo)atrophic islets, and a description of the spatial relationship of the infiltrate to the insulin-positive islet cells
Literature
1.
go back to reference Gepts W (1965) Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 14:619–633PubMed Gepts W (1965) Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 14:619–633PubMed
2.
go back to reference Foulis AK, Liddle CN, Farquharson MA, Richmond JA, Weir RS (1986) The histopathology of the pancreas in type 1 (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom. Diabetologia 29:267–274PubMedCrossRef Foulis AK, Liddle CN, Farquharson MA, Richmond JA, Weir RS (1986) The histopathology of the pancreas in type 1 (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom. Diabetologia 29:267–274PubMedCrossRef
3.
go back to reference Eisenbarth GS (1986) Type I diabetes mellitus. A chronic autoimmune disease. New Eng J Med 314:1360–1368PubMedCrossRef Eisenbarth GS (1986) Type I diabetes mellitus. A chronic autoimmune disease. New Eng J Med 314:1360–1368PubMedCrossRef
4.
go back to reference In’t Veld P (2011) Insulitis in human type 1 diabetes: the quest for an elusive lesion. Islets 3:131–138PubMedCrossRef In’t Veld P (2011) Insulitis in human type 1 diabetes: the quest for an elusive lesion. Islets 3:131–138PubMedCrossRef
5.
go back to reference Pipeleers D, Ling Z (1992) Pancreatic beta cells in insulin-dependent diabetes. Diab Metab Rev 8:209–227CrossRef Pipeleers D, Ling Z (1992) Pancreatic beta cells in insulin-dependent diabetes. Diab Metab Rev 8:209–227CrossRef
6.
go back to reference Willcox A, Richardson SJ, Bone AJ, Foulis AK, Morgan NG (2008) Analysis of islet inflammation in human type 1 diabetes. Clin Exp Immunol 155:173–181CrossRef Willcox A, Richardson SJ, Bone AJ, Foulis AK, Morgan NG (2008) Analysis of islet inflammation in human type 1 diabetes. Clin Exp Immunol 155:173–181CrossRef
7.
go back to reference Löhr M, Klöppel G (1987) Residual insulin positivity and pancreatic atrophy in relation to duration of chronic type 1 (insulin-dependent) diabetes mellitus and microangiopathy. Diabetologia 30:757–762PubMedCrossRef Löhr M, Klöppel G (1987) Residual insulin positivity and pancreatic atrophy in relation to duration of chronic type 1 (insulin-dependent) diabetes mellitus and microangiopathy. Diabetologia 30:757–762PubMedCrossRef
8.
go back to reference Keenan HA, Sun JK, Levine J et al (2010) Residual insulin production and pancreatic beta cell turnover after 50 years of diabetes: Joslin Medalist study. Diabetes 59:2846–2853PubMedCrossRef Keenan HA, Sun JK, Levine J et al (2010) Residual insulin production and pancreatic beta cell turnover after 50 years of diabetes: Joslin Medalist study. Diabetes 59:2846–2853PubMedCrossRef
9.
go back to reference Gianani R, Campbell-Thompson M, Sarkar SA et al (2010) Dimorphic histopathology of long-standing childhood-onset diabetes. Diabetologia 53:690–698PubMedCrossRef Gianani R, Campbell-Thompson M, Sarkar SA et al (2010) Dimorphic histopathology of long-standing childhood-onset diabetes. Diabetologia 53:690–698PubMedCrossRef
10.
go back to reference Coppieters KT, Dotta DF, Amirian N et al (2012) Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from diabetes patients. J Exp Med 209:51–60PubMedCrossRef Coppieters KT, Dotta DF, Amirian N et al (2012) Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from diabetes patients. J Exp Med 209:51–60PubMedCrossRef
11.
go back to reference Itoh N, Hanafusa T, Miyazaki A et al (1993) Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients. J Clin Invest 92:2313–2322PubMedCrossRef Itoh N, Hanafusa T, Miyazaki A et al (1993) Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients. J Clin Invest 92:2313–2322PubMedCrossRef
12.
go back to reference Butler AE, Galasso R, Meier JJ, Basu R, Rizza RA, Butler PC (2007) Modestly increased beta cell apoptosis but no increased beta cell replication in recent-onset type 1 diabetic patients who died of ketoacidosis. Diabetologia 50:2323–2331PubMedCrossRef Butler AE, Galasso R, Meier JJ, Basu R, Rizza RA, Butler PC (2007) Modestly increased beta cell apoptosis but no increased beta cell replication in recent-onset type 1 diabetic patients who died of ketoacidosis. Diabetologia 50:2323–2331PubMedCrossRef
13.
go back to reference Campbell-Thompson M, Wasserfall C, Kaddis J et al (2012) Network for pancreatic organ donors with diabetes (nPOD): developing a tissue biobank for type 1 diabetes. Diabetes Metab Res Rev 28:608–617PubMedCrossRef Campbell-Thompson M, Wasserfall C, Kaddis J et al (2012) Network for pancreatic organ donors with diabetes (nPOD): developing a tissue biobank for type 1 diabetes. Diabetes Metab Res Rev 28:608–617PubMedCrossRef
14.
go back to reference In't Veld P, Lievens D, de Grijse J et al (2007) Screening for insulitis in adult autoantibody-positive organ donors. Diabetes 56:2400–2404PubMedCrossRef In't Veld P, Lievens D, de Grijse J et al (2007) Screening for insulitis in adult autoantibody-positive organ donors. Diabetes 56:2400–2404PubMedCrossRef
15.
go back to reference In’t Veld PA, de Munck N, van Belle K et al (2010) Beta cell replication is increased in donor organs from young patients after prolonged life support. Diabetes 59:1702–1708PubMedCrossRef In’t Veld PA, de Munck N, van Belle K et al (2010) Beta cell replication is increased in donor organs from young patients after prolonged life support. Diabetes 59:1702–1708PubMedCrossRef
16.
go back to reference Campbell-Thompson M, Dixon LR, Wasserfall C et al (2009) Pancreatic adenocarcinoma patients with localised chronic severe pancreatitis show an increased number of single beta cells, without alterations in fractional insulin area. Diabetologia 52:262–270PubMedCrossRef Campbell-Thompson M, Dixon LR, Wasserfall C et al (2009) Pancreatic adenocarcinoma patients with localised chronic severe pancreatitis show an increased number of single beta cells, without alterations in fractional insulin area. Diabetologia 52:262–270PubMedCrossRef
17.
go back to reference Gepts W, de Mey J (1978) Islet cell survival determined by morphology: an immunocytochemical study of the islets of Langerhans in juvenile diabetes mellitus. Diabetes 27(Suppl 1):251–261PubMedCrossRef Gepts W, de Mey J (1978) Islet cell survival determined by morphology: an immunocytochemical study of the islets of Langerhans in juvenile diabetes mellitus. Diabetes 27(Suppl 1):251–261PubMedCrossRef
Metadata
Title
The diagnosis of insulitis in human type 1 diabetes
Authors
M. L. Campbell-Thompson
M. A. Atkinson
A. E. Butler
N. M. Chapman
G. Frisk
R. Gianani
B. N. Giepmans
M. G. von Herrath
H. Hyöty
T. W. Kay
O. Korsgren
N. G. Morgan
A. C. Powers
A. Pugliese
S. J. Richardson
P. A. Rowe
S. Tracy
P. A. In’t Veld
Publication date
01-11-2013
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 11/2013
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-013-3043-5

Other articles of this Issue 11/2013

Diabetologia 11/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.